FLT3 and acute promyelocytic leukemia: Furthermore, 10–50% of all patients with APL exhibit FLT3 mutations, either as internal tandem duplications or kinase domain mutations (10), and FLT3 mutations generally correlate with high white blood cell (WBC) counts (>10×109/l), which are indicative of higher patient risk of relapse (6).